Literature DB >> 24206188

The neuroprotective effect of carnosine (β-alanyl-L-histidine) on retinal ganglion cell following ischemia-reperfusion injury.

Yong-Sok Ji1, Jung-Won Park, Hwan Heo, Jong-Seong Park, Sang-Woo Park.   

Abstract

PURPOSE: To investigate whether carnosine can increase retinal ganglion cell (RGC) survival in ischemic mouse retina.
METHODS: Retinal ischemia was induced by constant elevation of intraocular pressure (100-110 mmHg) for 60 min in C57BL/6 J mice pretreated with carnosine (1000 mg/kg) or saline. Hypoxia inducing factor-1 alpha (HIF-1α), glial fibrillary acidic protein (GFAP), and dynamin-related protein-1 (Drp-1) expressions were assessed at 6, 12, and 24 h after retinal ischemia. Bax and Bcl-2 expressions were also analyzed at 12 h after retinal ischemia. RGC survival was assessed by retrograde FluoroGold labeling at 2 weeks after retinal ischemia.
RESULTS: The expression of HIF-1α, GFAP, and Drp-1 was increased within 24 h after ischemic injury. Carnosine treatment effectively decreased the elevated expression of HIF-1α, GFAP, and Drp-1 in ischemic mouse retina. In ischemic retina treated with carnosine, Bax expression was decreased, whereas Bcl-2 expression was increased compared with ischemic retina treated with saline. Carnosine treatment also protected against RGC loss in ischemia mouse retina.
CONCLUSIONS: Our findings showed that carnosine treatment significantly decreased RGC loss through decreased expression of HIF-1α, GFAP, Drp-1, and Bax, and increased expression of Bcl-2 in ischemic mouse retina. We suggest that carnosine can be an effective endogenous neuroprotective molecule in the prevention of RGC loss in ischemic retina.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24206188     DOI: 10.3109/02713683.2013.855235

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Comparison of pre-treatment and post-treatment use of selenium in retinal ischemia reperfusion injury.

Authors:  Alper Yazici; Hasan Aksit; Esin Sogutlu Sari; Arzu Yay; Haydar Ali Erken; Dilek Aksit; Harun Cakmak; Kamil Seyrek; Sitki Samet Ermis
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury.

Authors:  Rossella Russo; Annagrazia Adornetto; Federica Cavaliere; Giuseppe Pasquale Varano; Dario Rusciano; Luigi Antonio Morrone; Maria Tiziana Corasaniti; Giacinto Bagetta; Carlo Nucci
Journal:  Mol Vis       Date:  2015-06-29       Impact factor: 2.367

Review 3.  Neuroprotection in Glaucoma: Old and New Promising Treatments.

Authors:  Dario Rusciano; Salvatore Pezzino; Maria Giulia Mutolo; Rossella Giannotti; Aloisa Librando; Nicola Pescosolido
Journal:  Adv Pharmacol Sci       Date:  2017-10-17

4.  HIF inhibitor topotecan has a neuroprotective effect in a murine retinal ischemia-reperfusion model.

Authors:  Hiromitsu Kunimi; Yukihiro Miwa; Yusaku Katada; Kazuo Tsubota; Toshihide Kurihara
Journal:  PeerJ       Date:  2019-10-04       Impact factor: 2.984

5.  NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma.

Authors:  Hui Chen; Yang Deng; Xiaoliang Gan; Yonghao Li; Wenyong Huang; Lin Lu; Lai Wei; Lishi Su; Jiawen Luo; Bin Zou; Yanhua Hong; Yihai Cao; Yizhi Liu; Wei Chi
Journal:  Mol Neurodegener       Date:  2020-04-15       Impact factor: 14.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.